Invention Grant
- Patent Title: Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer
-
Application No.: US16306352Application Date: 2017-06-02
-
Publication No.: US11419927B2Publication Date: 2022-08-23
- Inventor: Gustav Gaudernack , Audun Tornes
- Applicant: Ultimovacs AS
- Applicant Address: NO Oslo
- Assignee: Ultimovacs AS
- Current Assignee: Ultimovacs AS
- Current Assignee Address: NO Oslo
- Agency: HoustonHogle LLP
- Priority: EP16172760 20160602
- International Application: PCT/EP2017/063589 WO 20170602
- International Announcement: WO2017/207814 WO 20171207
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/28 ; A61P35/04 ; A61P35/00
Abstract:
A polypeptide for use in medicine is provided. The polypeptide is administered simultaneously, separately or sequentially with an immune checkpoint inhibitor. The polypeptide comprises at least one polypeptide comprising a region of at least 12 amino acids of a self-antigen or a sequence having at least 80% identity to the region. The polypeptide is less than 100 amino acids in length.
Public/Granted literature
- US20190247482A1 A VACCINE IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR USE IN TREATING CANCER Public/Granted day:2019-08-15
Information query
